Avasimibe, an inhibitor of the cholesterol esterification enzyme ACAT1, increases cholesterol levels in the cell membrane, facilitating the formation of immune synapses and signal transduction, resulting in superior anti-tumor efficacy in different mouse models [99,100]. The gene discussed is ACAT1; the disease is neoplasm.